Research institute
The FDA gave the green light to Amgen’s Lumakras under accelerated approval as a treatment for patients with KRAS mutation whose disease has worsened over time.
The FDA has a massive backlog of site inspections due to the pandemic. To address the problem, the agency made its Resiliency Roadmap outlining its priorities.
Determined to take its next-generation engineered cell therapies to the next level, BlueRock teams up with Senti Biosciences with futuristic medicines in mind.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
BioSpace looks at five of the top investor companies that support life sciences companies across the industry.
The company says it plans to file an IND for the candidate, dubbed CFT8919, by the middle of next year.
Engine is ready to drive its lead program into clinical trials by 2023 while Giiant’s preclinical program will target moderate-to-severe ulcerative colitis.
Emergent said the vaccine candidate against the mosquito-borne illness showed an increase in immune response as measured by anti-chikungunya virus SNA.
The Francis Crick Institute and the Latvian Institute of Organic Synthesis developed a new compound that blocks the life cycle of the mosquito-borne parasite that causes malaria.
The disclosure comes the day before the WHO is expected to plan for the next phase of investigations into the origins of COVID-19.
PRESS RELEASES